c Exophiala species are capable of causing cutaneous and subcutaneous infections in immunocompromised patients. An Exophiala isolate was cultured from a biopsy specimen of a lesion on the forearm of a patient with myasthenia gravis. The patient also had lesions on the palm and distal aspects of the hand, which were successfully treated with a long-term course of itraconazole. A detailed morphological and molecular characterization of the isolate was undertaken. Phylogenetic analysis of the internal transcribed spacer region and portions of the -tubulin and translation elongation factor 1-alpha genes indicated that the isolate was a novel species closely related to but genetically distinct from species within the Exophiala spinifera clade; the name Exophiala polymorpha sp. nov. is proposed. Morphologically, E. polymorpha most closely resembles E. xenobiotica but it differs in possessing phialides bearing prominent, wide collarettes, and it does not produce chlamydospores. E xophiala species are phaeoid, conidial fungi that are widely distributed in decaying wood, soil, plants, and water. They are capable of causing phaeohyphomycosis, including localized infections following traumatic implantation to disseminated disease (1, 2). Although cutaneous/subcutaneous phaeohyphomycosis incited by Exophiala species is relatively uncommon, several species of black yeasts identified by molecular means have been reported as etiologic agents. In the largest study to date in which 188 clinical isolates were characterized by internal transcribed spacer (ITS) sequencing and phenotypic features (3), 38.3% and 0.5% of the study isolates were from cutaneous and superficial sites, respectively. Subcutaneous isolates represented 12% of the strains and included Exophiala bergeri, E. dermatitidis, E. jeanselmei, E. lecanii-corni, E. mesophila, E oligosperma, E. phaeomuriformis, E. spinifera, and E. xenobiotica. While limited clinical information precluded documentation of these isolates as etiologic agents, their recovery and characterization highlighted the diversity of species seen in the clinical setting. A sampling of literature reports shows some of the same species seen in the above study, including E. oligosperma as an agent of olecranon bursitis (4), disseminated subcutaneous disease in a patient with systemic lupus erythematosus (5), and a patient with Wegener's granulomatosis (6), multiple reports of E. spinifera cutaneous/subcutaneous disease (7,8), and E. xenobiotica in a patient with non-Hodgkin lymphoma (9). We report here subcutaneous sporotrichoid lesions by Exophiala polymorpha, sp. nov. in a patient with myasthenia gravis.
CASE REPORTThe patient is a 68-year-old African-American woman who complained of a right palmar painless nodule of about 6 months' duration prior to presentation. She reported that the lesion started like a callus in the middle of her right palm. This lesion gradually enlarged, and she started having sporotrichoid nodular lesions developing on the dorsum of her hand, wrist, forearm, and antecubita...